Trade Mark Journal No.2025/052 26 December 2025

WO0000001890312 (5)

Office of origin: United States of America

Date of International Registration:6 November 2025
Date of designation in the UK: 6 November 2025
Image for mark 1890312 NELKARMI

International priority date claimed: 19 May 2025 (United States of America) (99192492)
Class 5
Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders.

Nuvalent, Inc.

Representative: Joshua S. Jarvis Foley Hoag LLP, 155 Seaport Blvd., Boston MA 02210-2600, UNITED STATES OF AMERICA